LIVE GMP

Shellz India Ltd₹0·Tonbo Imaging India Ltd₹+498·Zetwerk Manufacturing Business Ltd₹+22·Bonfiglioli Transmissions Ltd₹+160·Sahajanand Medical Technologies Ltd₹+46·Ravita Engineering Services Ltd₹+4·Fusion CX Ltd₹+17·Jio Platforms Ltd₹+222·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Dove Soft Ltd₹0·Omara Ventures India Ltd₹0·Shellz India Ltd₹0·Tonbo Imaging India Ltd₹+498·Zetwerk Manufacturing Business Ltd₹+22·Bonfiglioli Transmissions Ltd₹+160·Sahajanand Medical Technologies Ltd₹+46·Ravita Engineering Services Ltd₹+4·Fusion CX Ltd₹+17·Jio Platforms Ltd₹+222·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Dove Soft Ltd₹0·Omara Ventures India Ltd₹0·

Sahajanand Medical Technologies Ltd

● OPEN NSE & BSE Bookbuilding IPO OFS only Sahajanand Medical Technologies IPO GMP

GREY MARKET PREMIUM

₹ + 46

+13% expected return

EST. LISTING PRICE

₹390

                    Issue Price: ₹
                    344                

Back to IPOs Check Allotment Website

Issue Price

₹344

Face Value

₹1

Lot Size

43 shares

IPO Size

Agg. upto ₹475 Cr

Open Date

15 Oct 2026

Close Date

19 Oct 2026

Allotment

21 Oct 2026

Listing Date

23 Oct 2026

Exchange

NSE & BSE

About Financials Ratios IPO Issue Details IPO Subscription Contact Disclaimer

Sahajanand Medical Technologies IPO Details: Price, Dates & Financials

The Sahajanand Medical Technologies IPO key financial ratios show a Return on Capital Employed (ROCE) of 3.16%. The Sahajanand Medical Technologies IPO Return on Equity (ROE) is 2.07%. The Sahajanand Medical Technologies IPO reports a Return on Net Worth (RONW) of 2.31%. For profitability analysis, the Sahajanand Medical Technologies IPO reports a Profit After Tax (PAT) margin of 4.29%. The Sahajanand Medical Technologies IPO EBITDA margin is 13.81%. Compare these Sahajanand Medical Technologies IPO key ratios with listed peers and read the offer document before taking a decision.

Sahajanand Medical Technologies IPO Key Financial Ratios

ROE

2

ROCE

3

RONW

2

PAT Margin

4

EBITDA Margin

14

Debt/Equity

0

Sahajanand Medical Technologies IPO Key Ratios FAQs

What are the ROE, ROCE and RONW of Sahajanand Medical Technologies IPO?

As per the offer document, Sahajanand Medical Technologies has ROE 2.07%, ROCE 3.16%, RONW 2.31%.

What is the PAT margin and EBITDA margin of Sahajanand Medical Technologies IPO?

Sahajanand Medical Technologies reports PAT margin 4.29% and EBITDA margin 13.81%.

What is the debt to equity ratio of Sahajanand Medical Technologies IPO?

The debt-to-equity ratio of Sahajanand Medical Technologies is 0.33. A lower ratio generally means the company relies less on borrowed money.

What do ROE, ROCE and RONW mean in the Sahajanand Medical Technologies IPO?

ROE (return on equity) shows profit earned on shareholders' money, ROCE (return on capital employed) shows profit earned on all capital used in the business, and RONW (return on net worth) measures return on the company's net worth. Higher figures usually indicate more efficient use of capital.

How to use key ratios to compare Sahajanand Medical Technologies IPO with its peers?

Compare ROE, ROCE, margins and P/BV of Sahajanand Medical Technologies with listed companies in the same sector, and check the peer comparison given in the offer document. Ratios are only one input — they do not predict listing gains.

Why do we require these key ratios for the Sahajanand Medical Technologies IPO to work with?

We require these key ratios to evaluate the financial health, profitability, valuation, and overall performance of the Sahajanand Medical Technologies IPO. They help investors understand how efficiently the company operates, how much debt it carries, and whether its shares are reasonably valued compared with its earnings and assets for that specific Sahajanand Medical Technologies IPO. These ratios also help assess the Sahajanand Medical Technologies IPOs ability to generate profits, manage financial obligations, and deliver sustainable growth, enabling investors to make a more informed Sahajanand Medical Technologies IPO investment decision.

What Should Investors Look for in the Sahajanand Medical Technologies IPO's Financial Performance?

Investors should examine the Sahajanand Medical Technologies IPO's revenue growth, profitability, debt levels, cash flow, and earnings per share (EPS). These indicators help assess the Sahajanand Medical Technologies IPO's financial stability, growth potential, and investment risks before investing in the Sahajanand Medical Technologies IPO.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.